Sovereign Nations. Different Laws. One Complicated Payments System.
Sovereign Nations. Different Laws. One Complicated Payments System. On Indigenous Peoples' Day, it's time to examine why tribal gaming, ...
Meta Description: Former Suntory Holdings CEO Takeshi Niinami resigns amid police investigation into US-imported CBD supplement in Japan, where cannabis derivatives face strict legal restrictions despite growing global CBD market acceptance.
Takeshi Niinami, former chief executive of Japanese beverage giant Suntory Holdings, has resigned his position following investigation by police in Fukuoka, southwestern Japan, on suspicion of possessing an illegal substance, while maintaining his innocence regarding a CBD supplement, according to reporting by the Associated Press.
"I have not broken the law. I believe I am innocent," Niinami told reporters on September 3, 2025. The executive explained the case involved what he described as "a CBD supplement" manufactured in the United States and recommended by a friend who sent it to him by mail. CBD, or cannabidiol, is a component derived from cannabis plants.
Niinami stated he assumed the supplement was "legal 100%" and wanted to try the product, which cost less than versions sold in Japan, to help relieve jet lag from overseas travel. He indicated he was traveling when the package arrived and did not personally receive it.
Police in Fukuoka confirmed Niinami was being investigated in a possible drug case but declined to provide additional details. The investigation's scope, specific substances involved, and potential charges have not been publicly disclosed.
Suntory Holdings President Nobuhiro Torii, a member of the company's founding family, held a news conference on September 2, 2025, to announce Niinami's resignation. Torii declined to provide many details about the circumstances, stating the case remained under investigation.
The timing and nature of the resignation—occurring during an active investigation rather than after its conclusion—suggests significant concern within the company about potential reputational impacts. Suntory has not indicated whether Niinami will face additional consequences beyond resignation or whether the company conducted internal investigations into the matter.
Japan maintains strict prohibitions on cannabis and cannabis-derived products, with legal frameworks that differ substantially from many Western nations where CBD products have become widely available. While CBD derived from hemp containing minimal THC concentrations is legal in many countries, Japan's Cannabis Control Act prohibits cannabis possession and use with limited exceptions.
The legal status of CBD products in Japan depends on specific formulations and whether they contain any THC (tetrahydrocannabinol), the primary psychoactive compound in cannabis. Pure CBD isolate products containing zero THC may be legal, but products containing even trace THC amounts—which are common in some international CBD formulations—violate Japanese law.
Japanese regulations also prohibit importing cannabis or cannabis derivatives without proper authorization, regardless of their legal status in the country of origin. International mail containing cannabis-related substances may be intercepted by customs officials, potentially triggering criminal investigations even if recipients did not personally accept delivery.
The incident highlights regulatory disparities between Japan and countries like the United States, where CBD products derived from hemp became federally legal following the 2018 Farm Bill. In the US and many other nations, CBD supplements are widely available through retail channels, online platforms, and direct-to-consumer sales.
CBD products marketed for various health purposes including sleep support, anxiety reduction, pain management, and general wellness have proliferated in Western markets. However, efficacy claims for many applications lack robust clinical evidence, and product quality varies significantly due to limited regulatory oversight in some jurisdictions.
The price differential Niinami mentioned—seeking less expensive alternatives to products available in Japan—reflects the premium pricing often associated with CBD products in markets with limited supply or restrictive regulations. This pricing dynamic can incentivize cross-border purchasing, potentially creating legal risks when destination countries maintain stricter cannabis regulations than source countries.
The resignation of a major corporation's CEO over a personal legal matter raises questions about corporate governance standards and executive conduct expectations in Japan. Whether Suntory's board required the resignation or Niinami voluntarily stepped down to protect the company's reputation remains unclear.
Japanese corporate culture typically emphasizes institutional reputation preservation, with executives often resigning to accept responsibility for issues that might not result in immediate legal consequences in other business cultures. The speed of Niinami's departure—occurring during investigation rather than after resolution—may reflect these cultural considerations.
Suntory Holdings operates as one of Japan's largest beverage companies, with brands including Suntory whisky, beer products, soft drinks, and bottled water. The company has significant international operations and marketing partnerships, making executive conduct and reputation management particularly important for maintaining brand value and stakeholder relationships.
The founding family's continued involvement in company leadership, represented by President Torii, provides institutional continuity but may also intensify pressure to address potential controversies decisively to protect the family business legacy.
The investigation's outcome and potential charges against Niinami remain undetermined. Japanese legal proceedings in drug-related cases can extend over months, with investigation phases preceding any formal charging decisions. Whether prosecutors will pursue charges based on the investigation findings, and what penalties might be sought if charges are filed, cannot be predicted at this stage.
Niinami's statement asserting innocence suggests he may contest any potential charges, though the basis for his defense—believing the product was legal and not personally receiving the package—would require evaluation under Japanese legal standards governing possession and importation.
The incident illustrates risks associated with purchasing dietary supplements and health products across international borders without verifying compliance with destination country regulations. Products legal in manufacturing countries may violate destination country laws due to ingredient restrictions, concentration limits, or prohibited substance classifications.
Consumers considering international supplement purchases should research destination country regulations, understand customs enforcement policies, and recognize that legal responsibility for prohibited imports may attach even without personal receipt of packages. Relying on friends' recommendations or cost savings without independent regulatory verification creates legal exposure in jurisdictions with strict substance control laws.
This article reports on developments originally covered by the Associated Press.
As CBD and hemp-derived products face varying regulations across international markets, manufacturers and distributors need comprehensive compliance systems to verify legal status, ingredient specifications, and regulatory requirements in each jurisdiction.
Qredible's Q-Trust quality management platform provides multi-jurisdictional regulatory tracking, product formulation compliance verification, import/export documentation management, and ingredient restriction monitoring for CBD, hemp, and cannabis-derived product companies operating internationally.
Contact our team to learn how our international compliance solutions can help your business navigate complex cross-border regulations, maintain documentation for customs compliance, and ensure products meet legal requirements in diverse international markets with varying cannabis and hemp regulations.
